Full cohort (n = 430) | Observer study Cohort (n = 152) | |
---|---|---|
Age (y) | 48 (30–70) | 50 (33–70) |
DM compressed breast thickness (mm) | 47 (19–78) | 48 (20–76) |
BI-RADS density category | A: 10 B: 106 C: 217 D: 97 | A: 6 B: 31 C: 69 D: 46 |
Ground truth | Malignant: 42 Benign: 114 Normal: 274 | Malignant: 42 Benign: 30 Normal: 80 |
Histology of malignant lesions (42 lesions in 42 patients) | Invasive ductal carcinoma: 32 Ductal carcinoma in situ: 3 Mucinous carcinoma: 2 Intraductal papillary carcinoma: 2 Metaplastic carcinoma: 1 Neuroendocrine carcinoma: 1 Apocrine carcinoma: 1 | Invasive ductal carcinoma: 32 Ductal carcinoma in situ: 3 Mucinous carcinoma: 2 Intraductal papillary carcinoma: 2 Metaplastic carcinoma: 1 Neuroendocrine carcinoma: 1 Apocrine carcinoma: 1 |
Histology of benign lesions (Full Cohort: 152 lesions in 114 patients, 38 patients had two benign lesions; Observer Study Cohort: 35 lesions in 30 patients, 5 patients had two benign lesions) | Fibroadenoma: 79 Cyst: 1 Intraductal papillary: 11 Radial scar: 1 Atypical Ductal Hyperplasia: 6 Lipoma: 1 Phyllodes tumor: 2 Hamartoma: 1 Sclerosing adenosis: 2 Benign hyperplasia: 48 | Fibroadenoma: 14 Intraductal papillary: 3 Atypical Ductal Hyperplasia: 2 Lipoma: 1 Phyllodes tumor: 2 Hamartoma: 1 Benign hyperplasia: 12 |